Inventor · disambiguated record
Howell F. Moffett
Also filed as: MOFFETT HOWELL · MOFFETT HOWELL F · MOFFETT HOWELL FRANKLIN
5 granted patents·4 pending applications·10 citations·filing 2017–2024
69Inventor score
Files withFRED HUTCHINSON CANCER CENTER3LYELL IMMUNOPHARMA INC3OUTPACE BIO INC2HUTCHINSON FRED CANCER RES1
Top patents by PatentIndex Score
9 records- 0189US10188749B2Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriersHUTCHINSON FRED CANCER RES·Filed 2017·Granted Jan 29, 2019·9 cites·8 claims
- 0277US11872195B2Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriersFRED HUTCHINSON CANCER CENTER·Filed 2018·Granted Jan 16, 2024·1 cites·19 claims
- 0370US2024409610A1Novel Recombinant Cell Surface MarkersLYELL IMMUNOPHARMA INC·Filed 2024·Application pending·0 cites
- 0463US12054531B2Recombinant cell surface markersLYELL IMMUNOPHARMA INC·Filed 2021·Granted Aug 6, 2024·0 cites·28 claims
- 0563US2024285797A1Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarrierFRED HUTCHINSON CANCER CENTER·Filed 2024·Application pending·0 cites
- 0661US12144827B2ROR1 targeting chimeric antigen receptorLYELL IMMUNOPHARMA INC·Filed 2022·Granted Nov 19, 2024·0 cites·20 claims
- 0755US2025223330A1Designed cytokine compositions and methods of useOUTPACE BIO INC·Filed 2023·Application pending·0 cites
- 0853US2023159615A1Chimeric polypeptidesOUTPACE BIO INC·Filed 2022·Application pending·0 cites
- 0948US11578118B2Systems and methods to produce B cells genetically modified to express selected antibodiesFRED HUTCHINSON CANCER CENTER·Filed 2018·Granted Feb 14, 2023·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Howell F. Moffett files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →